Full Text View
Tabular View
No Study Results Posted
Related Studies
Role of Metabolites in Nicotine Dependence (3) - 6
This study has been completed.
Study NCT00000289   Information provided by National Institute on Drug Abuse (NIDA)

First Received on September 20, 1999.   Last Updated on November 3, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Tobacco Use Disorder
More general conditions related to this trial
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Ondansetron
Additional drug interventions recognized in this trial
Nicotine
More general drug interventions related to this trial
Anti-Anxiety Agents
Antiemetics
Antipruritics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Cholinergic Agents
Cholinergic Agonists
Dermatologic Agents
Ganglionic Stimulants
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
University of Minnesota - Clinical and Translational Science Institute


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services